June 3 - 6, 2024
pharma
For Abbott, Libre Soars, Baby Formula Rebounds, COVID Tests Plummet
- by Les Luchter , October 18, 2023
In third quarter earnings released Wednesday, Abbott Laboratories reported continued soaring sales of its Freestyle Libre diabetes device, a near return-to-normal in its infant formula business, and, as expected, plummeting sales for COVID testing.
Sales of the Freestyle Libre continuous glucose monitor rose 28% year-over-year to $1.4 billion. There are …
